NICE has recommended Eisai’s Kisplyx (lenvatinib) in combination with Novartis’ Afinitor (everolimus) in kidney cancer after the company further dropped its price.
A dramatic veto from Northern Ireland’s Democratic Unionist Party (DUP) saw Theresa May’s hopes of clinching a ‘divorce settlement’ with the European Union collapse yesterday.
